Source: MDedge | Hematology& Oncology Hydroxychloroquine is currently first-line, and tocilizumab second-line, for people hospitalized with polymerase chain reaction–confirmed COVID-19 in the Yale New Haven
Source: MedRxiv Abstract Importance: Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs and high mortality. The most urgent thing is to find
The records review reported outcomes where hydroxychloroquine alone was provided to our sickest COVID-19 patients. The Veterans who received hydroxychloroquine were at highest risk prior
Source: MedRxiv Importance: Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs and high mortality. The most urgent thing is to find effective
Source: medRxiv View ORCID Profile Mohammad Ali Ashraf, Nasim Shokouhi, Elham Shirali, Fateme Davari-tanha, Omeed Memar, View ORCID Profile Alireza Kamalipour, Ayein Azarnoush, Avin Mabadi, Adele Ossareh, Milad Sanginabadi, Talat Mokhtari Azad, Leila Aghaghazvini, Sara Ghaderkhani, Tahereh Poordast, Alieh Pourdast, Pershang Nazemi
In an official statement, Bahrain’s, Ministry of health said: Bahrain has received a shipment of Hydroxychloroquine, following the export approval issued by the government of
The Federal Council of Medicine ( CFM ) authorized the use of chloroquine and hydroxychloroquine in patients infected with Covid-19 , a disease caused by the new coronavirus, showing mild symptoms. According to the
The U.S. Department of Justice on Monday cited “extreme urgency” in clearing U.S. pharmaceutical distributors from legal hurdles in order to provide the controversial anti-malaria
This study focuses on anti-malarial drugs like hydroxychloroquine, which have been seen as the most used treatment for COVID-19
SOURCE: Covexit The advanced copy of a new study, by Rodrigo Barbosa Esper M.D., Ph.D. and collaborators has just been circulated. The study analyzes the
The Russian government has authorized hospitals to treat coronavirus patients with the untested malaria drug hydroxychloroquine. Thursday’s decree instructs Russia’s national medical cardiology research center to distribute
Source: Washington Examiner Watch the excerpt: South Dakota will be the first U.S. state to hold a statewide trial for hydroxychloroquine as a possible treatment of the
Source: Science Direct PhilippeGautretab1Jean-ChristopheLagierac1PhilippeParolaabVan ThuanHoangabdLineMeddebaJacquesSevestreaMorganeMailheaBarbaraDoudieraCamilleAubryaSophieAmraneaPisethSengaMarieHocquartaCaroleEldinabJulieFinanceeVera EstevesVieiraaHervé TissotTissot-DupontacStéphaneHonoréfgAndreasSteinacMatthieuMillionacPhilippeColsonacBernardLa ScolaacVéroniqueVeithAlexisJacquieriJean-ClaudeDeharojMichelDrancourtacPierre EdouardFournierabJean-MarcRolainacPhilippeBrouquiacDidierRaoultac aIHU-Méditerranée Infection, Marseille, France bAix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France cAix Marseille Univ,
Untranslated Source: Ukraine Government Translation begins: Ukraine will receive an additional 320 thousand hydroxychloroquine tablets for the treatment of COVID-19 patientsApril 9, 2020 The Ministry
On 24 March 2020, new restrictions came into effect limiting the health practitioners who could initiate therapy with hydroxychloroquine. These were introduced following reports of
On the 2nd of April, the Federal Government made and exemption to standard TGA ruling to allow for the emergency importation of hydroxychloroquine for the
The Morrison government has waived therapeutic goods registration requirements for anti-malarial drugs to prepare for their urgent importation to Australia. On Thursday, hydroxychloroquine and chloroquine
The U.S. Food and Drug Administration (FDA) has approved the use of two anti-malaria drugs to treat patients infected by the new coronavirus. On Sunday, the
The Russian Health Ministry has provided Version 4 (27/03/2020) interim recommendations for the treatment of COVID-19, which includes their intended dosage and timeline of use.
In recent days there has been considerable focus on the potential for hydroxychloroquine and the similar compound chloroquine (which is not marketed in Australia) to
Source medRxiv Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial Zhaowei Chen, View ORCID ProfileJijia Hu, Zongwei Zhang, Shan Jiang, Shoumeng Han, Dandan Yan, Ruhong Zhuang, Ben Hu, View ORCID ProfileZhan Zhangdoi: https://doi.org/10.1101/2020.03.22.20040758This article is a preprint and
As leading doctors warn of widespread infection in Jordan, hospitals can now use malaria drug for serious conditions. Jordan’s Food and Drug Administration (FDA) authorised
Source: National Library of Medicine Conclusion: Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19
To increase the effectiveness of treatments and results, researchers need to give greater focus, when designing trials and when extrapolating from them.
At the WHO’s media briefing on COVID-19, the Director-General’s opening remarks included: “WHO has been assessing this outbreak around the clock and we are deeply
Doctors of subordinate Moscow medical institutions are invited to participate in the study of the drug for the prevention of COVID-19. A medicine called hydroxychloroquine is
Hydroxychloroquine (HCQ) appears as an additional therapy, as it possesses immunomodulatory and anti-thrombotic various effects [4-16].
Chloroquine and hydroxychloroquine, with an original indication to prevent or cure malaria, have been successfully used to treat several infectious diseases.
Scientific evidence also supports the use of CQ and HCQ in the treatment of cancer.
Here, we summarize the results or design of clinical studies recently completed or initiated to evaluate the therapeutic activity of chloroquine derivatives in cancer patients.
HCQ reduces lipopolysaccharide/TLR-mediated immune activation; this compound could be a useful immunomodulant in HIV-infected patients.
This suggests that intracellular Zn2+ levels affect a common step in the replicative cycle of these viruses.
Source: PLOS Pathogens Author: Aartjan J. W. te Velthuis,Sjoerd H. E. van den Worm,Amy C. Sims,Ralph S. Baric,Eric J. Snijder ,Martijn J. van Hemert Abstract Increasing
Source: VirologyJournal.com Abstract Background Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently
The anti-HIV effect of chloroquine/hydroxychloroquine is modest by itself but is additive or synergistic when combined with selected antiretrovirals.
Source: PubMed.com Abstract Exposure of influenza B virus-infected MDCK cells to chloroquine at the time of infection resulted in significant inhibition of infection. The appearance
